The legal adaption measures expected from pharma groups
December 01, 2022 | 13:00
Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
Preparing MNCs for a global tax rate
July 27, 2022 | 10:36
The introduction of a global minimum corporate tax on the foreign profits of multinational corporations will affect Vietnam’s own tax plans. Annett Perschmann-Taubert, tax partner at PwC Vietnam, discussed with VIR’s Luu Huong the current tax landscape and how policies should be reformed in order to maintain momentum.
Vietnam to benefit from large corporations’ capital relocations
July 10, 2022 | 15:40
Capital reallocation plans announced by multinational corporations will offer opportunities for Vietnam to attract foreign direct investment, experts said.
MNCs wait for clear drug registration to get ahead
December 31, 2021 | 14:34
While keeping strong business and investment plans in Vietnam, multinational corporations continue to seek more favourable timelines for innovative pharma registration to further facilitate future expansions.
Multinationals grasp incentives
November 18, 2021 | 17:00
A number of multinational corporations are planning to venture further into local production to enjoy incentives and to benefit from the landmark EU-Vietnam Free Trade Agreement.
Pharma landscape set for shake-up
March 11, 2020 | 11:00
Facing significant expansion from multinational corporations, Vietnamese drug giants took a hit in 2019 despite new strategies, signalling an uninspiring outlook for future growth.
Mobile Version